EUVIMEDDescoperă EUVIMED
Systematische ÜbersichtMetaanalyseÜbersichtsarbeitOpen access

Remotely Supervised, Home-Based Transcranial Direct Current Stimulation for Major Depressive Disorder: Systematic Review and Meta-Analysis

Motti Haimi, Natália Almeida-Antunes, Simao Pedro Rodrigues Ferreira, Nuno Barbosa Rocha

JMIR Mental Health · 2026-09-04 · 13 · e92522-e92522

DOI: 10.2196/92522 ↗

At a glance

Systematische Übersicht in JMIR Mental Health, published online on 2026-09-04. Written by Motti Haimi and 3 co-authors. Institution: Health Systems Management Department, The Max Stern Yezreel Valley College, D.N Emek Yezreel, Mizra, Northern District, 1930600, Israel, 972 04-642-3…. Major MEDLINE topics: Transcranial Direct Current Stimulation, Major Depressive Disorder, Home Care Services. 59 references. The full text is freely available in PubMed Central.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Major depressive disorder affects over 280 million people worldwide, and access to effective treatment remains limited. Transcranial direct current stimulation (tDCS) is a noninvasive option, and portable devices now allow for home-based delivery under varying degrees of remote supervision.

Objective

This study aimed to systematically review and meta-analyze the efficacy, safety, feasibility, and acceptability of home-based and remotely supervised tDCS for depressive disorders.

Methods

Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 and PRISMA-S (Preferred Reporting Items for Systematic Reviews and Meta-Analyses literature search extension) guidelines, we searched MEDLINE, Embase, Web of Science, the Cochrane databases, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform up to July 2025, with backward and forward citation searching. Two reviewers independently screened records, extracted data, and assessed risk of bias (version 2 of the Cochrane risk-of-bias tool for randomized trials, Newcastle-Ottawa Scale for observational studies, and Critical Appraisal Skills Programme for qualitative studies) and certainty of evidence (Grading of Recommendations Assessment, Development, and Evaluation; GRADE).

Results

This review included 12 distinct studies (16 reports), of which 6 (50%) were randomized sham-controlled trials forming the meta-analytic pool. Active home-based tDCS produced a small, statistically significant improvement over sham (pooled Hedges g =0.36, 95% CI 0.06-0.66; P =.03; I 2 =34.3%). The effect was not robust to removal of the single largest positive trial (omitting the one study from 2025: g =0.39, 95% CI −0.12 to 0.91), and trial-level results were mixed: the 2 largest trials (one unsupervised [n=210] and one self-administered [n=141]) were negative on their primary depression outcomes, whereas the largest real-time supervised trial (n=174) was positive (between-group 95% CI 0.51‐4.01; P =.01). This estimate was concordant in direction with an independent peer-reviewed meta-analysis of overlapping trials, which reported a pooled Montgomery-Åsberg Depression Rating Scale reduction (weighted mean difference −2.74, 95% CI −4.19 to −1.29) and Hamilton Depression Rating Scale reduction (weighted mean difference −2.24, 95% CI −4.16 to −1.49), attenuating to nonsignificance ( P >.05) in major depressive disorder without comorbid cognitive impairment. The pooled effect fell at or near the minimal clinically important difference. GRADE certainty was moderate. Adverse events were predominantly mild: one pilot study was terminated early for skin lesions, and one nonfatal suicide attempt occurred in an unsupervised trial.

Conclusions

Home-based and remotely supervised tDCS produces a small, statistically significant but clinically modest antidepressant effect that is sensitive to the inclusion of the largest positive trial, with the 2 largest trials being negative. The available controlled evidence does not establish supervision intensity as a determinant of efficacy. Current data are insufficient to recommend routine clinical adoption; adequately powered trials with standardized supervision and longer follow-up are needed.

Subjects

MeSH terms (MEDLINE)

Transcranial Direct Current StimulationMajor Depressive DisorderHome Care ServicesHumans

Author keywords

brain stimulationhome-based treatmentmajor depressive disordermeta-analysisremote supervisionsystematic reviewtelemedicinetranscranial direct current stimulation

Authors and institutions

  • Health Systems Management Department, The Max Stern Yezreel Valley College, D.N Emek Yezreel, Mizra, Northern District, 1930600, Israel, 972 04-642-3423.
  • The Ruth and Bruce Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
  • RISE-Health, Center for Translational Health and Medical Biotechnology (TBIO), ESS, Technical University of Porto, Porto, Portugal.

Cite

APA

Haimi, M., Almeida-Antunes, N., Rodrigues Ferreira, S. P., & Barbosa Rocha, N. (2026). Remotely Supervised, Home-Based Transcranial Direct Current Stimulation for Major Depressive Disorder: Systematic Review and Meta-Analysis. JMIR Mental Health, 13, e92522-e92522. https://doi.org/10.2196/92522

Vancouver

Haimi M, Almeida-Antunes N, Rodrigues Ferreira SP, Barbosa Rocha N. Remotely Supervised, Home-Based Transcranial Direct Current Stimulation for Major Depressive Disorder: Systematic Review and Meta-Analysis. JMIR Mental Health. 2026;13:e92522-e92522. doi:10.2196/92522

BibTeX
@article{Haimi2026,
  author = {Haimi, Motti and Almeida-Antunes, Natália and Rodrigues Ferreira, Simao Pedro and Barbosa Rocha, Nuno},
  title = {Remotely Supervised, Home-Based Transcranial Direct Current Stimulation for Major Depressive Disorder: Systematic Review and Meta-Analysis},
  journal = {JMIR Mental Health},
  year = {2026},
  volume = {13},
  pages = {e92522--e92522},
  doi = {10.2196/92522}
}
Start for free →